Monitoring heparin therapy. 1977

D J Stevens, and R Latorraca

UI MeSH Term Description Entries
D001780 Blood Coagulation Tests Laboratory tests for evaluating the individual's clotting mechanism. Coagulation Tests, Blood,Tests, Blood Coagulation,Blood Coagulation Test,Coagulation Test, Blood,Test, Blood Coagulation
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013923 Thromboembolism Obstruction of a blood vessel (embolism) by a blood clot (THROMBUS) in the blood stream. Thromboembolisms

Related Publications

D J Stevens, and R Latorraca
January 1983, Revue medicale de Bruxelles,
D J Stevens, and R Latorraca
January 1994, Annals of internal medicine,
D J Stevens, and R Latorraca
January 1994, Annals of internal medicine,
D J Stevens, and R Latorraca
December 1976, American journal of hospital pharmacy,
D J Stevens, and R Latorraca
October 1993, Minerva medica,
D J Stevens, and R Latorraca
June 1978, American journal of surgery,
D J Stevens, and R Latorraca
February 1991, La Clinica terapeutica,
D J Stevens, and R Latorraca
November 1991, Clinical pharmacy,
D J Stevens, and R Latorraca
January 1978, Annales pharmaceutiques francaises,
D J Stevens, and R Latorraca
July 1994, CAP today,
Copied contents to your clipboard!